EXOSOMM Looks to the Benefits of Mother's Milk to Bring New Bioactive Ingredient for Medical Food Space
JERUSALEM, May 3, 2023 /PRNewswire/ -- BioFoodTech start-up EXOSOMM, Ltd., has explored the natural mechanisms inherent in human breastmilk to create a novel bioactive ingredient that can potentially support millions of adults with inflammatory disorders. Based on its scientific findings EXOSOMM developed an innovative technology that isolates exosomes—natural particles in maternal milk that play an important role in the healthy development of the immune system.
- EXOSOMM upcycles byproducts of the traditional cheese making process to create this potent functional ingredient.
- While still a young start-up, it has already reached commercial production capacity of its patent-protected exosomes for the medical food space.
- Moreover, it was important for us to derive the milk benefits without exerting any burden on milk production.
- EXOSOMM has been selected as a finalist in the Most Innovative Nutraceutical Ingredient category at the upcoming Vitafoods Startup Innovation Challenge 2023.